Skip to main content
LABT
NASDAQ Life Sciences

Lakewood-Amedex Expands Global IP Portfolio for Lead Drug Nu-3 with New Patents in Australia, New Zealand

Tom Rudovsky · Reported by PR Newswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.698
Mkt Cap
$9.981M
52W Low
$0.66
52W High
$9.82
52W Position info
5.8% above low
Off High info
93% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

LABT is trading near its 52-week low of $0.66 (5.8% above the low) on light trading volume (0.1× avg).

Summary

Lakewood-Amedex announced the issuance of two new patents in Australia and New Zealand for the gel formulation of its lead candidate, Nu-3, which targets infected diabetic foot ulcers. This expands the company's global intellectual property portfolio to 71 granted patents and 28 pending applications. Strengthening IP for its core asset is a positive development for the micro-cap biotech, providing long-term protection and enhancing future commercial opportunities. This news follows recent positive data for Nu-3 and a highly dilutive Series C financing round. The company plans to advance Nu-3 into a Phase 2 clinical trial.

At the time of this announcement, LABT was trading at $0.70 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10M. The 52-week trading range was $0.66 to $9.82. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

LABT - Latest Insights

LABT
Sep 28, 2026, 5:49 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.07
Real-time Price: $0.3804 info
Change: -$0.6896 (-64%) info
Market Cap: $453.558K info
LABT
Sep 24, 2026, 8:02 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $1.80
Real-time Price: $0.3804 info
Change: -$1.42 (-79%) info
Market Cap: $453.558K info
LABT
Sep 18, 2026, 5:30 PM EDT
Filing Type: S-1
Importance Score:
7
Price at Filing: $1.94
Real-time Price: $0.3804 info
Change: -$1.56 (-80%) info
Market Cap: $453.558K info
LABT
Aug 13, 2026, 9:36 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.28
Real-time Price: $0.3804 info
Change: -$1.90 (-83%) info
Market Cap: $453.558K info
LABT
Aug 10, 2026, 5:13 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $2.36
Real-time Price: $0.3804 info
Change: -$1.98 (-84%) info
Market Cap: $453.558K info